Compare Cardinal Health Inc (CAH) vs Devon Energy Corp (DVN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cardinal Health Inc vs Devon Energy Corp — how do they compare? Cardinal Health Inc trades at $231.36 (market cap $54.46B), while Devon Energy Corp trades at $44.7 (market cap $49.35B). The key difference: Cardinal Health Inc and Devon Energy Corp are close in size by market cap, and Devon Energy Corp pays the higher dividend (2.85%). Which is the better fit depends on your goals.
| CAH | DVN | |
|---|---|---|
Market Cap | $54.46B | $49.35B |
Sector | Health | Energy |
52-Week High | $240.26 | $52.07 |
52-Week Low | $146.04 | $31.74 |
Enterprise Value | $58.49B | $60.08B |
Dividend Yield | 0.88% | 2.85% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cardinal Health (CAH) trades at $231.24, down 3.75% on the day, following a strong earnings beat in Q2 2026 with EPS of $2.91 versus $2.42 expected. The stock is in a bullish technical trend with moving averages supporting further upside, while fundamentals show robust revenue growth and improved profitability, with a net income margin of 0.67% for 2025. Recent news highlights record highs post-earnings and optimistic fiscal 2027 guidance.
The outlook for CAH is positive, driven by consistent earnings beats, strong analyst buy ratings (54.55%), and a consensus price target of $270.11 implying significant upside. Key risks include high leverage with a debt-to-asset ratio of 16.09 and reliance on pharmaceutical and specialty business segments for growth amidst competitive pressures.
Devon Energy (DVN) trades at $44.39, down 2.22% on the day, with a bullish technical signal from moving averages and neutral oscillators. The company reported strong Q2 2026 results, beating EPS estimates by 21% and revenue by 18%, while raising its dividend 33% and accelerating share buybacks. Valuation metrics appear attractive with a P/E of 9.75 and EV/EBITDA of 6.82, supported by a net income margin of 16.67% and positive operating cash flow of $6.71 billion in 2025.
The outlook remains positive given robust free cash flow generation, debt reduction progress, and merger synergies from the Coterra integration. Key risks include oil price volatility and execution of synergy targets. With 71% analyst buy ratings and a consensus price target of $61.91, the stock offers potential upside from current levels if operational momentum continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cardinal Health Inc
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →About Devon Energy Corp
Devon Energy, based in Oklahoma City, is one of the largest independent exploration and production companies in North America. The firm's asset base is spread throughout onshore North America and includes exposure to the Delaware, STACK, Eagle Ford, Powder River Basin, and Bakken plays. At year-end 2021, Devon's proved reserves totaled 1.6 billion barrels of oil equivalent, and net production that year was 572 thousand boe/d, of which oil and natural gas liquids made up 74% of production, with natural gas accounting for the remainder.
Read more on DVN →
